Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Hemangiopericytoma


See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Newline Maker

What treatment is available for meningeal hemangiopericytoma?

Radical surgical resection with removal of all meningeal attachments is typically the preferred treatment. However this treatment option is generally possible in only 50-67% of patients who have meningeal hemangiopericytoma. Embolization prior to surgery is recommended because of the excessive bleeding associated with these tumors.[1] Embolization is a method of stopping the blood flow to the tumor. This can be done mechanicially or through the use of chemicals that cause blood vessels to close. If chemicals that kill cells are used during embolization the procedure is referred to as chemoembolization.[2]
Last updated: 11/19/2013

References
  1. Kaba SE, Kyritsis AP. Section 10: Neurological Malignancies. Chapter 58: Atypical and Malignant Malinomas. In: Raghavan D, Brecher ML, Johnson DH, Meropol NJ, Moots PL, Rose PG. Textbook of Uncommon Cancer Third Edition. England: John Wiley & Sons, Ltd; 2006;
  2. Hogle WP. Malignant Hemangiopericytoma. Clinical Journal of Oncology Nursing. January/February 2003;


Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Hemangiopericytoma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.